The Health Commission of Iran Regime’s Majlis (Parliament) confirmed that 70 dialysis patients have died in Iran due to medication contaminated with aluminum. According to Salman Es’haghi, the commission’s spokesperson, not only has no serious legal action been taken against the producer of this solution in the past three months, but the company has also been given another order to produce the medication.
Es’haghi did not name the manufacturing company, but independent reports indicate that Samen Pharmaceutical Company, affiliated with financial institutions of the Iranian regime, is the producer of these toxic solutions.
The Majlis member explained that initial reports cited the deaths of 10 to 12 dialysis patients in the cities of Mashhad and Isfahan, which later rose to 50. It is now confirmed that 70 people have lost their lives.
According to Es’haghi, the initial discussion of dialysis patient deaths centered on the use of “substandard medication.” Later, it was suggested that the medication might have been contaminated with aluminum, and investigations revealed that the company had been “negligent” in this regard.
He mentioned that the commission’s investigation has been ongoing for over three months, and the judiciary should have taken serious actions. However, the same company has again been asked to continue producing the medication.
Following this Majlis member’s statements, the public relations office of the Food and Drug Administration released a statement saying, “Currently, only one domestic company is responsible for producing this critical medication, but this does not mean that quality or standards are being overlooked.”
Earlier, on June 12, the Food and Drug Administration announced it had received “initial reports indicating some issues and complications following the use of peritoneal dialysis solutions produced by Samen Pharmaceutical Company.”
According to Ham-Mihan newspaper, the main shareholders of this company, in order of their stake, include Astan Quds Razavi with around 70 percent, the Pension Fund with approximately 26 percent, and Hakim Pharmaceutical Company with four percent. Astan Quds Razavi is one of the entities under the supervision of Ali Khamenei, the Supreme Leader of Iran’s regime, and has faced recent reports of corruption in other sectors as well.
The contaminated batch of peritoneal dialysis solutions was distributed from January 2024 and claimed dozens of lives by May.
According to Salman Es’haghi, 800,000 patients in Iran rely on peritoneal dialysis for treatment.
Dialysis patients who used this aluminum-contaminated solution died after experiencing neurological, infectious, seizure-related, and coma symptoms.
